Berry Genomics Co (000710.SZ) Stock Price

Berry Genomics Co Price

SZSE·CLOSED
10.27
​
Market closed

Over the last 19 years Berry Genomics Co grew revenue by 10.1% annually, reaching 929.82 M CNY. Earnings per share have grown at 35.8% per year over the last 14 years. For Berry Genomics Co, the net margin of -21.2% is down versus -7.8% a few years ago.

Berry Genomics Co stock price

Access this data via the Eulerpool API

Berry Genomics Co business model & stock analysis

Berry Genomics Co., Ltd. engages in the gene detection and sales of equipment and reagents of high-throughput sequencing technology. The company is headquartered in Beijing, Beijing and currently employs 1,438 full-time employees. The firm's business is comprised of basic scientific research services, medical testing services, testing reagent sales and testing equipment sales. The basic scientific research services business provides the clients with multiple sequencing platforms for testing projects, such as transcriptome sequencing, human whole exome sequencing and whole genome sequencing. The medical testing services business include tumor genetic testing services, genetic disease genetic testing services and reproductive health testing services. The firm sells a range of reagents and equipment, including NextSeq CN500 gene sequencer and general reagents for sequencing reactions.

Frequently asked questions about Berry Genomics Co

5 analysts currently rate the Berry Genomics Co stock: 4 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Berry Genomics Co share trades at 1.37 EUR (10.27 CNY).

The Berry Genomics Co share (000710.SZ) is listed on 1 stock exchanges, including: Shenzhen (000710.SZ).

The revenue cannot currently be calculated for Berry Genomics Co.

The profit cannot currently be calculated for Berry Genomics Co.

The P/E ratio cannot be calculated for Berry Genomics Co at the moment.

The P/S cannot be calculated for Berry Genomics Co currently.

The Eulerpool Quality Score for Berry Genomics Co is 2/10.

The ISIN of Berry Genomics Co is CNE000000PN7. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Berry Genomics Co is 000710.SZ. The ticker symbol is used to trade Berry Genomics Co shares on the stock exchange.

Fair ValueTerminal
9.65 CNY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
646,605.01 CNY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
CNY
Initial public offering
Apr 22, 1997
ISIN
CNE000000PN7
Cusip
Y1306V103
Market capitalization
3.63 B CNYMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
2.46
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-13.33 %
Last updated Oct 9, 2026, 2:17 AM

Berry Genomics Co Peer Group

Berry Genomics Co Ticker

SHZ · 000710.SZ

Berry Genomics Co FIGI

000710:CH · BBG000D3JV36000710:CS · BBG000D3JWK5000710:C2 · BBG00JMZX5K6